Postoperative analgesia effect of sufentanil in different modality of patient-controlled analgesia in urology surgery
Han Miao-hua
Abstract
Han Miao-hua
Abstract
Objective:To investigate the postoperative analgesia effect of sufentanil in different modality of patient-controlled analgesia for patients undergoing urology surgery. Methods: Eighty ASA Ⅰ or Ⅱ patients undergone urology surgery were randomly divided into group A(PCIA)and B(PECA) (n=40 each). Patients in group A received sufentanil 100 μg + 100 ml normal saline while those in group B were administered sufentanil 50 μg+0.75% bupivacaine 15 ml+100 ml normal saline(two groups at a rate of 2 ml/h with PCA 0.5 ml/15 min). BP, ECG and SpO-2 were continuously monitored during postoperation. Postoperative pain was assessed by VAS score at 4,8,12,24 and 48 hours after operation with observation of adverse effects. Results: There was a satisfactory analgesia rate in each group, but group A got low scores of pain(VAS) than group B(P0.05), and scores of sedation in group B were lower than that of group A. No significant difference was seen among two groups on the rate of nausea, vomiting and heart and respiratory rate. Conclusion: The findings suggest that postoperative analgesia with sufentanil can provide satisfactory postoperative pain relief with less adverse effects for patients undergoing urology surgery.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the postoperative analgesia effect of sufentanil in different modality of patient-controlled analgesia for patients undergoing urology surgery. Methods: Eighty ASA Ⅰ or Ⅱ patients undergone urology surgery were randomly divided into group A(PCIA)and B(PECA) (n=40 each). Patients in group A received sufentanil 100 μg + 100 ml normal saline while those in group B were administered sufentanil 50 μg+0.75% bupivacaine 15 ml+100 ml normal saline(two groups at a rate of 2 ml/h with PCA 0.5 ml/15 min). BP, ECG and SpO-2 were continuously monitored during postoperation. Postoperative pain was assessed by VAS score at 4,8,12,24 and 48 hours after operation with observation of adverse effects. Results: There was a satisfactory analgesia rate in each group, but group A got low scores of pain(VAS) than group B(P0.05), and scores of sedation in group B were lower than that of group A. No significant difference was seen among two groups on the rate of nausea, vomiting and heart and respiratory rate. Conclusion: The findings suggest that postoperative analgesia with sufentanil can provide satisfactory postoperative pain relief with less adverse effects for patients undergoing urology surgery.
Key concepts: Sufentanil, Medicine, Anesthesia, Sedation, Nausea, Saline, Vomiting, Adverse effect